Skip to main
AVAH

AVAH Stock Forecast & Price Target

AVAH Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 13%
Buy 38%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Aveanna Healthcare Holdings Inc demonstrated strong financial performance, with revenue from its Private Duty Services (PDS) segment reaching $514.4 million, a 25.6% increase year-over-year, significantly exceeding expectations. The Home Health & Hospice (HHH) segment also showed robust growth, generating $62.4 million in revenue, which marks a 15.3% increase compared to the previous year, driven by a rise in total admissions. Furthermore, improved financial flexibility is indicated by a cash flow increase and a strong spread of $12.62, up 23.0% year-over-year, alongside raised revenue guidance of more than $2.375 billion, reflecting a positive outlook for the company.

Bears say

The analysis indicates several fundamental challenges facing Aveanna Healthcare Holdings Inc., contributing to a negative outlook on its stock. Key concerns include potential reimbursement pressures and increased competition, which could hinder the company's ability to achieve anticipated organic growth and successfully integrate acquisitions. Additionally, high leverage and ongoing labor headwinds are projected to contribute to a 10% reduction in FY26 adjusted EBITDA estimates, alongside a consistent decline in gross margins year-over-year.

AVAH has been analyzed by 8 analysts, with a consensus rating of Buy. 13% of analysts recommend a Strong Buy, 38% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aveanna Healthcare Holdings (AVAH) Forecast

Analysts have given AVAH a Buy based on their latest research and market trends.

According to 8 analysts, AVAH has a Buy consensus rating as of Mar 21, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10.31, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10.31, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aveanna Healthcare Holdings (AVAH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.